BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6522449)

  • 1. Suppositories containing beta-cyclodextrin complexes. Part 1: Stability studies.
    Szente L; Apostol I; Szejtli J
    Pharmazie; 1984 Oct; 39(10):697-9. PubMed ID: 6522449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring by headspace gaschromatography (HSGC) of formation and thermal stability of terpene beta-cyclodextrin complexes.
    Vincieri FF; Mazzi G; Papini P; Gelsomini N
    Farmaco Prat; 1986 Mar; 41(3):98-106. PubMed ID: 3709770
    [No Abstract]   [Full Text] [Related]  

  • 3. Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin.
    Uekama K; Imai T; Maeda T; Irie T; Hirayama F; Otagiri M
    J Pharm Sci; 1985 Aug; 74(8):841-5. PubMed ID: 4032267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stability test of chloramphenicol-beta-cyclodextrin-containing tablets].
    Szabó-Révész P; Pintye-Hódi K; Miseta M; Selmeczi B
    Pharmazie; 1988 Aug; 43(8):554-5. PubMed ID: 3237749
    [No Abstract]   [Full Text] [Related]  

  • 5. Solute-induced circular dichroism: drug discrimination by cyclodextrin.
    Han SM; Atkinson WM; Purdie N
    Anal Chem; 1984 Dec; 56(14):2827-30. PubMed ID: 6524659
    [No Abstract]   [Full Text] [Related]  

  • 6. [A structural study of the inclusion compound of piroxicam with beta-cyclodextrin by NMR].
    Miao ZC; Du ZH; Xu GF; Shi TS
    Yao Xue Xue Bao; 1988; 23(9):682-7. PubMed ID: 3256202
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of beta-cyclodextrin with bile salts in aqueous solutions.
    Miyajima K; Yokoi M; Komatsu H; Nakagaki M
    Chem Pharm Bull (Tokyo); 1986 Mar; 34(3):1395-8. PubMed ID: 3731354
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppositories containing cyclodextrin complexes. Part 2: Dissolution and absorption studies.
    Szente L; Apostol I; Gerlóczy A; Szejtli J
    Pharmazie; 1985 Jun; 40(6):406-7. PubMed ID: 4034649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.
    Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH
    Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072
    [No Abstract]   [Full Text] [Related]  

  • 10. Study of products containing mebendazole and beta-cyclodextrin.
    Kata M; Papp L
    Pharmazie; 1987 Jan; 42(1):65-6. PubMed ID: 3575409
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative structure-stability relationships among inclusion complexes of cyclodextrins. I: Barbituric acid derivatives.
    Lopata A; Darvas F; Stadler-Szóke A; Szejtli J
    J Pharm Sci; 1985 Feb; 74(2):211-3. PubMed ID: 3989695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion complexes of cinnarizine with beta-cyclodextrin in aqueous solution and in the solid state.
    Tokumura T; Ueda H; Tsushima Y; Kasai M; Kayano M; Amada I; Nagai T
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4179-84. PubMed ID: 6529813
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dissolution profiles of powdered inclusion compounds of sulfonamide drugs with beta-cyclodextrin].
    Chen JY; Tsai WY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Apr; 5(4):206-11. PubMed ID: 2769826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of a complex between the analgesic, 6-benzoyl-benzoxazolidinone (CERM 10194), and beta-cyclodextrin.
    Si-Nang L; Simond J; Schiff V; Trottier D; Pourrat A
    Pharm Acta Helv; 1985; 60(4):112-6. PubMed ID: 4011622
    [No Abstract]   [Full Text] [Related]  

  • 15. Improvement of chemical instability of digitoxin in aqueous solution by complexation with beta-cyclodextrin derivatives.
    Yoshida A; Yamamoto M; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):4075-80. PubMed ID: 3245985
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationships between crystallinity of beta-cyclodextrin and tablet characteristics.
    Nakai Y; Yamamoto K; Terada K; Kajiyama A
    Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):5110-2. PubMed ID: 3830437
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved competitive indicator methods for the study of alpha-cyclodextrin complexes.
    Pendergast DD; Connors KA
    J Pharm Sci; 1984 Dec; 73(12):1779-83. PubMed ID: 6527255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrin complexation of barbiturates in aqueous solution.
    Han SM; Purdie N
    Anal Chem; 1984 Dec; 56(14):2825-7. PubMed ID: 6524658
    [No Abstract]   [Full Text] [Related]  

  • 19. [Stabilization of chlorobutanol with beta-cyclodextrin in suppositories].
    Gyulai M; Apostol I
    Acta Pharm Hung; 1986 May; 56(3):125-8. PubMed ID: 3739724
    [No Abstract]   [Full Text] [Related]  

  • 20. Improving the aqueous stability of prostaglandin E2 and prostaglandin A2 by inclusion complexation with methylated-beta-cyclodextrins.
    Hirayama F; Kurihara M; Uekama K
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4237-40. PubMed ID: 6597735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.